A growing preference for public-private patnerships is spurring innovation and technology among Dutch pharmaceutical companies

Pharmaceutical Technology - July 2008

By Sean Milmo

The Netherlands is slowly emerging as a frontrunner in Europe when it comes to using public-private sector partnerships to develop and market new drugs. Innovations in manufacturing processes and technologies are also becoming a large part of the Dutch portfolio.

Please visit PharmTech.com for the full article.